Resiliency Program for Medical Interpreters (CARE)

March 3, 2015 updated by: Elyse Park, PhD, Massachusetts General Hospital

Developing a Resiliency Program for Medical Interpreters in Cancer Care

To develop and test a 4-session program to teach resiliency skills to Medical Interpreters.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

This study aims to improve quality of cancer care for LEP patients through improving medical interpreters' ability to cope with difficult encounters. We propose to (1) identify the needs of medical interpreters working with cancer patients, and (2) develop and test a psychoeducational resiliency program at 3 DF/HCC cancer centers: MGH, DFCI, and BWH) intended to enhance interpreters' skills to effectively manage stressful encounters and to cope with the personal effects of encounters.

Study Type

Interventional

Enrollment (Actual)

28

Phase

  • Phase 2
  • Phase 1

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  1. Interpreter employed at one of the 3 study hospitals
  2. >=20 hours/week

Exclusion Criteria:

1) Interpreter working <20 hours per week

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Delayed Intervention: Control
Delayed intervention: Control was a a behavioral treatment for resiliency delivered in a single 4 hour session delivered in a delayed fashion (waitlist control)
Behavioral: Behavioral: Resiliency Intervention
4 hour behavioral session including education in the relaxation response, education about stress and allostatic load, cognitive skills building, review of difficult encounters with patients.
Other Names:
  • CARE
Experimental: Experimental: Intervention
Experimental: Intervention was a 4 hour behavioral resiliency intervention.
Behavioral: Behavioral: Resiliency Intervention
4 hour behavioral session including education in the relaxation response, education about stress and allostatic load, cognitive skills building, review of difficult encounters with patients.
Other Names:
  • CARE

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Feasibility and Acceptability of Intervention (participant feedback questionnaire)
Time Frame: Post-Intervention (4 weeks)
A participant feedback questionnaire will be completed by participants, including questions about whether the logistics and content of the intervention were feasible and acceptable to them. Attendance to the sessions is also considered as a component of feasibility.
Post-Intervention (4 weeks)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Psychological Variables including Perceived Stress and Resiliency ( PSS-1021 is a 10-item scale)
Time Frame: Baseline, Post-Intervention (4 weeks), and 12 week follow up
The PSS-1021 is a 10-item scale designed to measure the degree to which situations in one's life are appraised, or considered as stressful, and how unpredictable, uncontrollable, and overloaded respondents find their lives. Responses are on 4-item Likert scales and range from 10-40; higher score = greater stress.The Resiliency Scale is a 14-item self-report measure to assess one's ability to successfully deal with adversity.
Baseline, Post-Intervention (4 weeks), and 12 week follow up

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Massachusetts General Hospital

Collaborators

University of Massachusetts, Boston

Investigators

  • Study Director: Michele Russell-Einhorn, JD, Dana-Farber Cancer Institute

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

January 1, 2014

Primary Completion (Actual)

March 1, 2014

Study Completion (Actual)

June 1, 2014

Study Registration Dates

First Submitted

June 27, 2014

First Submitted That Met QC Criteria

March 3, 2015

First Posted (Estimate)

March 4, 2015

Study Record Updates

Last Update Posted (Estimate)

March 4, 2015

Last Update Submitted That Met QC Criteria

March 3, 2015

Last Verified

February 1, 2015

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 12-524

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Psychological Stress

Clinical Trials on Behavioral: Resiliency Intervention

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Russia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe